GGrantIndex
Sort

51,593 grants matching hepatitis

HCV VARIANTS AND IMMUNE RESPONSE IN INJECTION DRUG USERS

$372,750
Northern California Institute Res &Educ · R01 · FY2003 · DA

HCV VARIANTS AND IMMUNE RESPONSE IN INJECTION DRUG USERS

$372,750
Northern California Institute Res &Educ · R01 · FY2002 · DA

HCV VARIANTS AND IMMUNE RESPONSE IN INJECTION DRUG USERS

$372,750
Northern California Institute Res &Educ · R01 · FY2000 · DA

Flavivirus non-coding RNAs and the Host mRNA Decay Machinery

$372,709
Jeffrey Wilusz · Colorado State University · R01 · FY2019 · AI

Flavivirus non-coding RNAs and the Host mRNA Decay Machinery

$372,709
Jeffrey Wilusz · Colorado State University · R01 · FY2020 · AI

Flavivirus non-coding RNAs and the Host mRNA Decay Machinery

$372,709
Jeffrey Wilusz · Colorado State University · R01 · FY2018 · AI

Flavivirus non-coding RNAs and the Host mRNA Decay Machinery

$372,709
Jeffrey Wilusz · Colorado State University · R01 · FY2017 · AI

Fatty liver in HIV infected individuals

$372,678
Samer Gawrieh · Indiana University Indianapolis · R01 · FY2017 · DK

Lymphotoxin/LIGHT in Lipoprotein Metabolism and Atherosclerosis

$372,621
Godfrey Shalom Getz · University Of Chicago · R01 · FY2007 · HL

Modulation of Antiviral Immunity and T cell Clonal Exhaustion by Inhibitory Receptors

$372,601
E. John Wherry · University Of Pittsburgh At Pittsburgh · P01 · FY2016 · AI

Testing of Standard Drugs for Mycobacterium Tuberculosis (MTB) in Animal Models for MTB

$372,598
Janice Endsley · University Of Texas Med Br Galveston · N01 · FY2021 · AI

Endogenous Aldosterone and Glucose Homeostasis

$372,586
James Matthew Luther · Vanderbilt University · R01 · FY2015 · DK

HCV NS4B: Translating molecular virology into novel antiviral therapies

$372,581
Jeffrey S Glenn · Stanford University · R01 · FY2013 · AI

Targeting DAMPs in Alcoholic Hepatitis

$372,541
Robert F. Schwabe · Columbia University Health Sciences · U01 · FY2017 · AA

Epigenetic regulation of liver transporters

$372,528
Frederick J Suchy · University Of Colorado Denver · R01 · FY2013 · DK

Neuroendocrine Regulation of Adipocyte Metabolism

$372,518
Matthias H Tschop · University Of Cincinnati · R01 · FY2010 · DK

Hedgehog Signaling and Cilia in Choroid Fissure Morphogenesis and Coloboma

$372,500
Kristen M Kwan · University Of Utah · R01 · FY2019 · EY

Oral delivery of insulin using ligand-directed nanoparticles that do not compete with physiological ligands

$372,500
Ravikumar N Majeti · University Of Alabama In Tuscaloosa · R01 · FY2021 · DK

Oral delivery of insulin using ligand-directed nanoparticles that do not compete with physiological ligands

$372,500
Ravikumar N Majeti · University Of Alabama In Tuscaloosa · R01 · FY2022 · DK

Oral delivery of insulin using ligand-directed nanoparticles that do not compete with physiological ligands

$372,500
Ravikumar N Majeti · University Of Alabama In Tuscaloosa · R01 · FY2023 · DK

MicroRNA-15a/16-mediated cytokine/chemokine reprogramming in Kupffer cells prevents the development of hepatocellular carcinoma

$372,485
Guisheng Song · University Of Minnesota · R01 · FY2025 · CA

MicroRNA-15a/16-mediated cytokine/chemokine reprogramming in Kupffer cells prevents the development of hepatocellular carcinoma

$372,485
Guisheng Song · University Of Minnesota · R01 · FY2022 · CA

Gene Expression and Manipulation of Coxiella Burnetii

$372,475
Michael F Minnick · Colorado State University · U54 · FY2007 · AI

Insulin Signaling and Metabolic Effects through CLK2 Kinase

$372,469
Pere Puigserver · Dana-Farber Cancer Inst · R01 · FY2013 · DK

Alcoholic Hepatitis Consortia: an intramural/extramural collaboration to unravel genetic determinants

$372,437
Laura E. Nagy · Cleveland Clinic Lerner Com-Cwru · U01 · FY2018 · AA